ArticleDiagnostic microbiology and infectious disease2022

Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay.

Scott J C Pallett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.